+44.4%
GSK vs UEC
+21.1%
+23.3%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | UEC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -2.1% | +2.6% | +0.6% |
| 7D | +1.1% | -3.8% | +4.9% | +1.2% |
| 30D | +6.3% | -13.5% | +19.8% | +6.5% |
| 3M | +1.8% | -40.5% | +42.3% | +2.6% |
| 6M | +1.7% | -56.7% | +58.3% | +3.0% |
| YTD | +6.5% | -43.0% | +49.5% | +6.9% |
| 1Y | +9.5% | -42.5% | +52.0% | +9.7% |
| 3Y | +65.3% | +11.6% | +53.7% | +59.0% |
| All | +44.4% | +21.1% | +23.3% | +39.1% |
Cumulative growth
Daily Returns
Daily percentage return beside UEC.
Daily Out/Under-Performance
Portfolio return minus UEC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UEC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded UEC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling